Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $43.1 million.

  • TriSalus Life Sciences' Shares Outstanding (Weighted Average) rose 6247.18% to $43.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.1 million, marking a year-over-year increase of 6247.18%. This contributed to the annual value of $25.3 million for FY2024, which is 16960.87% up from last year.
  • According to the latest figures from Q3 2025, TriSalus Life Sciences' Shares Outstanding (Weighted Average) is $43.1 million, which was up 6247.18% from $32.9 million recorded in Q2 2025.
  • TriSalus Life Sciences' Shares Outstanding (Weighted Average)'s 5-year high stood at $43.1 million during Q3 2025, with a 5-year trough of $309609.0 in Q4 2022.
  • Its 4-year average for Shares Outstanding (Weighted Average) is $19.6 million, with a median of $23.9 million in 2024.
  • In the last 5 years, TriSalus Life Sciences' Shares Outstanding (Weighted Average) plummeted by 9821.49% in 2023 and then surged by 525611.81% in 2024.
  • Over the past 4 years, TriSalus Life Sciences' Shares Outstanding (Weighted Average) (Quarter) stood at $309609.0 in 2022, then surged by 2934.71% to $9.4 million in 2023, then surged by 169.61% to $25.3 million in 2024, then surged by 69.97% to $43.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $43.1 million in Q3 2025, compared to $32.9 million in Q2 2025 and $28.5 million in Q1 2025.